Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Oren

Showing results (1-10 of 172) with videos related to

Pageof 18
Sort By:
Journal of Molecular Cell Biology|July 11, 2019
p53: not just a tumor suppressorMoshe Oren
Cold Spring Harbor Perspectives in Medicine|July 15, 2016
The Paradox of p53: What, How, and Why?Yael Aylon, Moshe Oren
Molecular Cell|January 21, 2004
Regulation of p53 by Mdm2: fate is in the numbersAyelet Shmueli, Moshe Oren
Current Opinion in Genetics & Development|January 16, 2002
The p53 and Mdm2 families in cancerDan Michael, Moshe Oren
Cell|July 2, 2005
Life, death, and ubiquitin: taming the muleAyelet Shmueli, Moshe Oren
Cell Cycle (Georgetown, Tex.)|March 19, 2010
NFκB and p53: A life and death affairMoshe Oren, Tomer Cooks
Molecular Cell|March 28, 2007
Mdm2: p53's lifesaver?Ayelet Shmueli, Moshe Oren
Cancer Cell|September 13, 2011
DePICTing p53 activation: a new nucleolar link to cancerLior Golomb, Moshe Oren
Molecular Oncology|August 20, 2011
p53: guardian of ploidyYael Aylon, Moshe Oren
Nature Reviews. Drug Discovery|October 10, 2022
Drugging p53 in cancer: one protein, many targetsOri Hassin, Moshe Oren
Pageof 18

Showing results (1-10 of 172) with videos related to

Sort By:
Pageof 18
Journal of Molecular Cell Biology|July 11, 2019
p53: not just a tumor suppressorMoshe Oren
Cold Spring Harbor Perspectives in Medicine|July 15, 2016
The Paradox of p53: What, How, and Why?Yael Aylon, Moshe Oren
Molecular Cell|January 21, 2004
Regulation of p53 by Mdm2: fate is in the numbersAyelet Shmueli, Moshe Oren
Current Opinion in Genetics & Development|January 16, 2002
The p53 and Mdm2 families in cancerDan Michael, Moshe Oren
Cell|July 2, 2005
Life, death, and ubiquitin: taming the muleAyelet Shmueli, Moshe Oren
Cell Cycle (Georgetown, Tex.)|March 19, 2010
NFκB and p53: A life and death affairMoshe Oren, Tomer Cooks
Molecular Cell|March 28, 2007
Mdm2: p53's lifesaver?Ayelet Shmueli, Moshe Oren
Cancer Cell|September 13, 2011
DePICTing p53 activation: a new nucleolar link to cancerLior Golomb, Moshe Oren
Molecular Oncology|August 20, 2011
p53: guardian of ploidyYael Aylon, Moshe Oren
Nature Reviews. Drug Discovery|October 10, 2022
Drugging p53 in cancer: one protein, many targetsOri Hassin, Moshe Oren
Pageof 18